Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35 (2013), Issue 4, Pages 221–227
http://dx.doi.org/10.1155/2013/276547
Clinical Study

Immune Activation and Viral Replication after Vaccination with an Influenza A H1N1 2009 Vaccine in HIV-Infected Children Receiving Antiretroviral Therapy

1Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
2Center for Emerging and Neglected Infectious Diseases, Mahidol University, Nakhon Pathom 73170, Thailand
3Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
4Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
5Innovation Center for Research and Development of Medical Diagnostic Technology Project and Department of Transfusion Medicine, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand

Received 7 June 2013; Revised 18 July 2013; Accepted 22 August 2013

Academic Editor: Ross Molinaro

Copyright © 2013 Nattawat Onlamoon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Sullivan, R. M. Jacobson, W. R. Dowdle, and G. A. Poland, “2009 H1N1 influenza,” Mayo Clinic Proceedings, vol. 85, no. 1, pp. 64–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Lin and K. L. Nichol, “Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome,” Archives of Internal Medicine, vol. 161, no. 3, pp. 441–446, 2001. View at Google Scholar · View at Scopus
  3. A. R. Zanetti, A. Amendola, S. Besana, A. Boschini, and E. Tanzi, “Safety and immunogenicity of influenza vaccination in individuals infected with HIV,” Vaccine, vol. 20, supplement 5, pp. B29–B32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Pinto, V. Blazevic, S. A. Anderson et al., “Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects,” Journal of Infectious Diseases, vol. 183, no. 7, pp. 1000–1008, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. W. A. O'Brien, K. Grovit-Ferbas, A. Namazi et al., “Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination,” Blood, vol. 86, no. 3, pp. 1082–1089, 1995. View at Google Scholar · View at Scopus
  6. S. I. Staprans, B. L. Hamilton, S. E. Follansbee et al., “Activation of virus replication after vaccination of HIV-1-infected individuals,” Journal of Experimental Medicine, vol. 182, no. 6, pp. 1727–1737, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Ramilo, P. J. Hicks, J. Borvak et al., “T cell activation and human immunodeficiency virus replication after influenza immunization of infected children,” Pediatric Infectious Disease Journal, vol. 15, no. 3, pp. 197–203, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Tasker, W. A. O'Brien, J. J. Treanor et al., “Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial,” Vaccine, vol. 16, no. 9-10, pp. 1039–1042, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. K. R. Fowke, R. D'Amico, D. N. Chernoff et al., “Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients,” AIDS, vol. 11, no. 8, pp. 1013–1021, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. McMichael and S. L. Rowland-Jones, “Cellular immune responses to HIV,” Nature, vol. 410, no. 6831, pp. 980–987, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Mahalingam, M. Peakman, E. T. Davies et al., “T cell activation and disease severity in HIV infection,” Clinical & Experimental Immunology, vol. 93, no. 3, pp. 337–343, 1993. View at Google Scholar
  12. M. Mahalingam, A. Pozniak, T. J. McManus, D. Vergani, and M. Peakman, “Cell cycling in HIV infection: analysis of in vivo activated lymphocytes,” Clinical and Experimental Immunology, vol. 102, no. 3, pp. 481–486, 1995. View at Google Scholar · View at Scopus
  13. M. Levacher, F. Hulstaert, S. Tallet, S. Ullery, J. J. Pocidalo, and B. A. Bach, “The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value,” Clinical and Experimental Immunology, vol. 90, no. 3, pp. 376–382, 1992. View at Google Scholar · View at Scopus
  14. J. M. Orendi, A. C. Bloem, J. C. C. Borleffs et al., “Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection,” Journal of Infectious Diseases, vol. 178, no. 5, pp. 1279–1287, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Bouscarat, M. Levacher-Clergeot, M.-C. Dazza et al., “Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1,” AIDS Research and Human Retroviruses, vol. 12, no. 1, pp. 17–24, 1996. View at Google Scholar · View at Scopus
  16. P. Ondoa, S. Koblavi-Dème, M.-Y. Borget, M. L. Nolan, J. N. Nkengasong, and L. Kestens, “Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Cote d'Ivoire,” Clinical and Experimental Immunology, vol. 140, no. 1, pp. 138–148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhang, H. Shang, Y. Jiang et al., “Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients,” Chinese Medical Journal, vol. 119, no. 23, pp. 1966–1971, 2006. View at Google Scholar · View at Scopus
  18. N. Onlamoon, S. Tabprasit, S. Suwanagool, S. Louisirirotchanakul, A. A. Ansari, and K. Pattanapanyasat, “Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand,” Virology, vol. 341, no. 2, pp. 238–247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. E. Greenberg, M. H. Lai, G. F. Hartel et al., “Response to a monovalent 2009 influenza A (H1N1) vaccine,” The New England Journal of Medicine, vol. 361, no. 25, pp. 2405–2413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. C. Zhu, H. Wang, H. H. Fang et al., “A novel influenza A, (H1N1) vaccine in various age groups,” The New England Journal of Medicine, vol. 361, no. 25, pp. 2414–2423, 2009. View at Google Scholar
  21. X. Liang, H. Wang, J. Wang et al., “Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial,” The Lancet, vol. 375, no. 9708, pp. 56–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. N. F. Crum-Cianflone, L. E. Eberly, C. Duplessis et al., “Immunogenicity of a monovalent 2009 influenza a (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults,” Clinical Infectious Diseases, vol. 52, no. 1, pp. 138–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Tebas, I. Frank, M. Lewis et al., “Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals,” AIDS, vol. 24, no. 14, pp. 2187–2192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Reuter, S. Yuan, P. A. Marx et al., “DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells,” Human Vaccines & Immunotherapeutics, vol. 8, no. 11, pp. 1648–1653, 2012. View at Google Scholar
  25. F. J. Salgado, J. Lojo, C. M. Fernández-Alonso et al., “Interleukin-dependent modulation of HLA-DR expression on CD4and CD8 activated T cells,” Immunology and Cell Biology, vol. 80, no. 2, pp. 138–147, 2002. View at Google Scholar